North Star Investment Management Corp. Gilead Sciences, Inc. Transaction History
North Star Investment Management Corp.
- $1.43 Billion
- Q3 2024
A detailed history of North Star Investment Management Corp. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 395 shares of GILD stock, worth $38,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
395
Previous 348
13.51%
Holding current value
$38,670
Previous $23,000
43.48%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,910Shares Held
1.02BCall Options Held
12MPut Options Held
9.03M-
Black Rock Inc. New York, NY121MShares$11.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.3 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$7.46 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.92 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.81 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $123B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...